Novel 2-(2-(4-aryloxybenzylidene) hydrazinyl)benzothiazole derivatives as anti-tubercular agents.
Vikas N Telvekar, Vinod Kumar Bairwa, Kalpana Satardekar, Anirudh Bellubi
Index: Bioorg. Med. Chem. Lett. 22 , 649-52, (2012)
Full Text: HTML
Abstract
A series of structurally novel, substituted 2-(2-(4-aryloxybenzylidene) hydrazinyl)benzothiazole derivatives incorporating 2-hydrazinyl benzothiazole and 4-(aryloxy)benzaldehyde were designed and synthesized using molecular hybridization approach. All the synthesized compounds exhibited promising activity (MIC 1.5-29.00μg/ml) against Mycobacteriumtuberculosis H37Rv strains of using REMA. Five of the evaluated compounds exhibit MIC <3.0μg/ml. Compound (E)-6-chloro-2-(2-(4-(2,4-dichlorophenoxy)benzylidene)hydrazinyl) benzothiazole showed MIC of 1.5μg/ml. Thus, this compound could act as a potential lead for further development of new anti-tubercular drugs.Copyright © 2011 Elsevier Ltd. All rights reserved.
Related Compounds
Related Articles:
2015-03-01
[Tuberculosis (Edinb.) 95(2) , 155-61, (2015)]
2014-12-01
[Tuberculosis (Edinb.) 94(6) , 701-7, (2015)]
2015-02-01
[PLoS Pathog. 11(2) , e1004645, (2015)]
2015-01-01
[Antimicrob. Agents Chemother. 59(1) , 136-44, (2014)]
2015-04-01
[J. Appl. Microbiol. 118(4) , 864-72, (2015)]